MS
Mesoblast
MSB.AX·ASXMelbourne AUFounded 2004100 employees
Small CapbiotechPublicImmunologyCardiology
Platform: Cell Ther
Market Cap
$0.4B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (MSB.AX)
Loading MSB.AX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Nidaosocimab | MSB-4257 | Preclinical | 1 | Aβ | ALLOvarian Ca | ||
| Doxafutibatinib | MSB-1427 | Phase 1 | 1 | BET | ACCNASH |
SEC Filings & Financial Documents
SEC filings are not available for ASX-listed companies.
Mesoblast trades on ASX (AU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)